ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC14534-100mg |
|
1019206-88-2 |
Regorafenib monohydrate
|
0 | C21H17ClF4N4O4 | |
GC14534-50mg |
|
1019206-88-2 |
Regorafenib monohydrate
|
0 | C21H17ClF4N4O4 | |
GC14534-10mg |
|
1019206-88-2 |
Regorafenib monohydrate
|
0 | C21H17ClF4N4O4 | |
GC14533-1g |
|
492-27-3 |
Kynurenic acid
|
0 | C10H7NO3 | |
GC14532-50mg |
|
1324003-64-6 |
TC-G 1006
|
0 | C21H16F3N3O3 | |
GC14532-10mg |
|
1324003-64-6 |
TC-G 1006
|
0 | C21H16F3N3O3 | |
GC14531-10mg |
|
201738-24-1 |
Glycerophospho-N-Oleoyl Ethanolamine
|
0 | C23H46NO7P | |
GC14531-5mg |
|
201738-24-1 |
Glycerophospho-N-Oleoyl Ethanolamine
|
0 | C23H46NO7P | |
GC14531-1mg |
|
201738-24-1 |
Glycerophospho-N-Oleoyl Ethanolamine
|
0 | C23H46NO7P | |
GC14530-1mg |
|
73168-24-8 |
(d(CH2)51,Tyr(Me)2,Arg8)-Vasopressin
|
0 | C52H74N14O12S2 | |
GC14527-10mg |
|
107756-30-9 |
A 61603 hydrobromide
|
0 | C14H19N3O3S.HBr | |
GC14527-5mg |
|
107756-30-9 |
A 61603 hydrobromide
|
0 | C14H19N3O3S.HBr | |
GC14527-1mg |
|
107756-30-9 |
A 61603 hydrobromide
|
0 | C14H19N3O3S.HBr | |
GC14526-1g |
|
905973-89-9 |
CGK733
|
0 | C23H18Cl3FN4O3S | |
GC14526-500mg |
|
905973-89-9 |
CGK733
|
0 | C23H18Cl3FN4O3S | |
GC14526-10mM (in 1mL DMSO) |
|
905973-89-9 |
CGK733
|
0 | C23H18Cl3FN4O3S | |
GC14526-50mg |
|
905973-89-9 |
CGK733
|
0 | C23H18Cl3FN4O3S | |
GC14526-10mg |
|
905973-89-9 |
CGK733
|
0 | C23H18Cl3FN4O3S | |
GC14525-50mg |
|
1355244-02-8 |
ML 190
|
0 | C27H32N6O3 | |
GC14525-10mg |
|
1355244-02-8 |
ML 190
|
0 | C27H32N6O3 | |